Abstract
Most of IHs do not need any therapy due to spontaneous regression, and medical treatment is currently only performed in complicated IHs by propranolol. In extremely rare situations, alternative medical therapies have to be administered, such as corticosteroids or vincristine. Interferon and other chemotherapeutics are no longer used. Other congenital vascular tumors that can easily be confounded with IH do not show spontaneous regression and have to be discriminated. In most cases, only clinical evolution or histology can help diagnose tufted angioma or subtypes of hemangioendothelioma. Surgery, laser therapy, embolization, and/or medical therapies are possible options. In addition, these other congenital vascular tumors often present with the Kasabach-Merritt phenomenon (KMP), including thrombocytopenia and activated consumptive coagulopathy. Guidelines for the medical therapy of KMP have been published, and corticosteroids in combination with vincristine were proposed as first-line therapy. Recently, the mTOR inhibitor rapamycin has been reported to show promising effects for congenital vascular tumors with or without KMP.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Zarem HA, Edgerton MT (1967) Induced resolution of cavernous hemangiomas following prednisolone therapy. Plast Reconstr Surg 39(1):76–83
Hasan Q et al (2001) Altered mitochondrial cytochrome b gene expression during the regression of hemangioma. Plast Reconstr Surg. 108(6):1471–1476
Blei F et al (1993) Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis. J Cell Physiol 155(3):568–578
Bennett ML et al (2001) Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol 137(9):1208–1213
Sadan N, Wolach B (1996) Treatment of hemangiomas of infants with high doses of prednisone. J Pediatr 128(1):141–146
Rossler J, Wehl G, Niemeyer CM (2007) Evaluating systemic prednisone therapy for proliferating haemangioma in infancy. Eur J Pediatr 167:813–815
Boon LM, MacDonald DM, Mulliken JB (1999) Complications of systemic corticosteroid therapy for problematic hemangioma. Plast Reconstr Surg 104(6):1616–1623
Fawcett SL et al (2004) Vincristine as a treatment for a large haemangioma threatening vital functions. Br J Plast Surg 57(2):168–171
Perez J, Pardo J, Gomez C (2002) Vincristine – an effective treatment of corticoid-resistant life-threatening infantile hemangiomas. Acta Oncol 41(2):197–199
Haisley-Royster C et al (2002) Kasabach-merritt phenomenon: a retrospective study of treatment with vincristine. J Pediatr Hematol Oncol 24(6):459–462
Drolet BA et al (2013) Consensus-derived practice standards plan for complicated Kaposiform hemangioendothelioma. J Pediatr 163(1):285–291
Gidding CE et al (1999) Vincristine revisited. Crit Rev Oncol Hematol 29(3):267–287
Enjolras O et al (2004) Vincristine treatment for function- and life-threatening infantile hemangioma. Arch Pediatr 11(2):99–107
Ezekowitz RA, Mulliken JB, Folkman J (1992) Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 326(22):1456–1463
Barlow CF et al (1998) Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy. J Pediatr 132.3(Pt 1):527–530
Sidky YA, Borden EC (1987) Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses. Cancer Res 47(19):5155–5161
Kuriyama DK et al (2010) Treatment of Gorham-Stout disease with zoledronic acid and interferon-alpha: a case report and literature review. J Pediatr Hematol Oncol 32(8):579–584
Hurvitz SA et al (2000) Successful treatment with cyclophosphamide of life-threatening diffuse hemangiomatosis involving the liver. J Pediatr Hematol Oncol 22(6):527–532
Hammill AM et al (2011) Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer 57(6):1018–1024
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Italia
About this chapter
Cite this chapter
Rössler, J. (2015). Other Medical Treatments for Infantile Hemangioma and Congenital Vascular Tumors. In: Mattassi, R., Loose, D., Vaghi, M. (eds) Hemangiomas and Vascular Malformations. Springer, Milano. https://doi.org/10.1007/978-88-470-5673-2_12
Download citation
DOI: https://doi.org/10.1007/978-88-470-5673-2_12
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-5672-5
Online ISBN: 978-88-470-5673-2
eBook Packages: MedicineMedicine (R0)